규제 업데이트
2026년 9월 28일•1분 읽기
FDA Discontinues Lactulose Oral/Rectal Solution (NDA017906)
The FDA has listed the Lactulose oral and rectal solution (product #001) as discontinued under NDA017906, sponsored by Solvay.
규제 업데이트
2026년 9월 23일•1분 읽기
SOLVAY's TRANMEP Tablet (Meprobamate 400mg) Discontinued – ANDA084369
FDA records show SOLVAY's oral tablet TRANMEP, containing 400 mg meprobamate, is listed as discontinued under application ANDA084369.
규제 업데이트
2026년 9월 3일•1분 읽기
FDA Approves ANDA083606 for Butabarital Sodium Oral Tablet
The FDA approved ANDA083606 for an oral tablet of butabarital sodium (16.2 mg) submitted by Solvay; the product is listed as discontinued.